Panacea Biotec Q1 loss narrows to Rs 28.27 cr The company had posted a net loss of Rs 35.26 crore from continuing and discontinued operations for the corresponding period of the previous fiscal, Panacea Biotec said in a regulatory filing.
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.